Status:

TERMINATED

Effect of Metformin on Frailty in 12 Subjects

Lead Sponsor:

Mayo Clinic

Conditions:

Aging

Inflammation

Eligibility:

All Genders

60+ years

Phase:

PHASE2

Brief Summary

This study will test whether chronic metformin administration will improve longevity of the cell, improves its machinery by reducing aging-related biochemical parameters and thereby improving physical...

Detailed Description

Heart disease is the number one cause of death in the United States and disproportionately affects older adults, underscoring the need to examine determinants of survivorship. Recognizing this gap, cu...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age ≥ 60 years
  • Stable CAD
  • Prediabetes (one of the following criteria should be met)
  • Fasting plasma glucose: 100-126 mg/dL
  • HbA1C: 5.7-6.4
  • Frailty (Short Physical Performance Battery: Score \<9)
  • Able to return for follow-up
  • Written informed consent
  • Exclusion criteria:
  • Pre-existing or new-onset diabetes
  • Any active malignancy, hematological disorder, post organ transplant, immunocompromised
  • Cancer requiring treatment in the past 3 years (other than non-melanoma skin cancer)
  • Dementia \[mini mental state examination (MMSE \<20)\]
  • Disability (need for assistance in \>2 of any six activities on Katz activities of daily living (ADL)46
  • Prior stroke with disability
  • Acute coronary syndrome \<3months or participating in cardiac rehabilitation
  • Severe Parkinson's
  • Hepatic insufficiency and/or chronic liver disease (cirrhosis)
  • Chronic kidney disease (GFR \< 45 mL/min)
  • Taking metformin for any indication
  • Acute alcohol intoxication
  • Known hypersensitivity to metformin hydrochloride
  • Acute/chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma

Exclusion

    Key Trial Info

    Start Date :

    May 24 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 16 2021

    Estimated Enrollment :

    7 Patients enrolled

    Trial Details

    Trial ID

    NCT03451006

    Start Date

    May 24 2018

    End Date

    December 16 2021

    Last Update

    November 17 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic in Rochester

    Rochester, Minnesota, United States, 55905

    Effect of Metformin on Frailty in 12 Subjects | DecenTrialz